An improved, practical and efficient protocol for the production of pretomanid (1) is described. Key to this optimization was the design and development of a novel synthetic strategy, which involves the preparation of key intermediate (S)-1-(tert-butyldimethylsilyloxy)-3-(2-chloro-4-nitro-1H-imidazol-1-yl) propan-2-ol (6) from 2-chloro-4-nitroimidazole (2) and (S)-epichlorohydrin (3) through nucleophilic substitution, hydrolysis and silicon etherification reactions, followed by further O-alkylation and intramolecular cyclization to obtain pretomanid with excellent quality and yield. The new route addressed the scalability issues that existed in the reported routes, in which the explosive 2,4-dinitroimidazole, expensive (S)-1-O-(tert-butyldimethylsilyl) glycidol and laborious workups can be avoided. Furthermore, this new synthetic route provides a more efficient method to pretomanid with the characteristics of cheap and easily available raw materials, mild experimental conditions, simple operation, ‘one-pot’ procedure, which is satisfied with the requirement of green chemistry and suitable for industrial production.